Wechselwirkungen von Antazida (Tums, Maalox, Mylanta)

Antazida erhöhen den pH-Wert im Magen und enthalten Metallionen, die viele Arzneistoffe binden und so deren Aufnahme verringern.

Antazida (Tums, Maalox, Mylanta) hat in den von uns erfassten FDA-Fachinformationen und Faktenblättern 98 dokumentierte Wechselwirkungen: 29 schwerwiegende, 33 mittelschwere, 20 geringfügige und 16, bei denen eine Fachinformation keine relevante Wechselwirkung berichtet. Jeder Eintrag unten zitiert den Satz, auf dem er beruht. Diese Seite (Kategorie: Rezeptfreies Präparat) ist ein Ausgangspunkt, kein Urteil über Ihre persönliche Situation.

Wechselwirkungen laut Fachinformation

Schwerwiegende Wechselwirkungen (29)

  • BaloxavirmarboxilVirostatikumSchwerwiegend

    Avoid coadministration of XOFLUZA with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (e.g., calcium, iron, magnesium, selenium, or zinc). (Fachinformation zu Baloxavirmarboxil, Arzneimittelwechselwirkungen)

  • Bictegravir, Emtricitabin und Tenofoviralafenamidantiretrovirales ArzneimittelSchwerwiegend

    Routine administration of BIXLENVO together with, or 2 hours after, antacids containing Al/Mg is not recommended. (Fachinformation zu Bictegravir, Emtricitabin und Tenofoviralafenamid, Arzneimittelwechselwirkungen)

  • BisacodylAbführmittelSchwerwiegend

    …change in bowel habits that lasts more than 2 weeks stomach pain, nausea or vomiting When using this product do not chew or crush tablet(s) do not use within 1 hour after taking an antacid or milk it may cause stomach discomfort, faintness, and cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. (Fachinformation zu Bisacodyl, Warnhinweise)

  • Antacids, Multivitamins or Dairy Products: Decreased absorption of Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride Capsules; do not take concomitantly. (Fachinformation zu Bismutsubcitrat, Metronidazol und Tetracyclin, Arzneimittelwechselwirkungen)

  • CalcitriolVitamin-D-AnalogonSchwerwiegend

    Magnesium-containing preparations (e.g., antacids) and calcitriol should not be used concomitantly in patients on chronic renal dialysis because such use may lead to the development of hypermagnesemia. (Fachinformation zu Calcitriol, Warnhinweise)

  • CalciumacetatPhosphatbinderSchwerwiegend

    Avoid the use of calcium supplements, including calcium-based nonprescription antacids, concurrently with calcium acetate capsules. (Fachinformation zu Calciumacetat, Warnhinweise und Vorsichtsmaßnahmen)

  • • Bile acid sequestering agents and aluminum-based antacids: Avoid concomitant use with CTEXLI. (Fachinformation zu Chenodesoxycholsäure, Arzneimittelwechselwirkungen)

  • ChininMalariamittelSchwerwiegend

    Concomitant administration of these antacids with quinine sulfate should be avoided. (Fachinformation zu Chinin, Arzneimittelwechselwirkungen)

  • DasatinibSchwerwiegend

    Antacids: Avoid concomitant use. (Fachinformation zu Dasatinib, Arzneimittelwechselwirkungen)

  • DeferasiroxEisenpräparatSchwerwiegend

    Do not take Exjade with aluminum-containing antacid preparations. (Fachinformation zu Deferasirox, Arzneimittelwechselwirkungen)

  • Intervention: Concomitant use of diclofenac sodium/misoprostol and magnesium-containing antacids is not recommended. (Fachinformation zu Diclofenac und Misoprostol, Arzneimittelwechselwirkungen)

  • DicycloverinAnticholinergikumSchwerwiegend

    Effect of Antacids Because antacids may interfere with the absorption of anticholinergic agents including dicyclomine hydrochloride, simultaneous use of these drugs should be avoided. (Fachinformation zu Dicycloverin, Arzneimittelwechselwirkungen)

  • DoxercalciferolVitamin-D-AnalogonSchwerwiegend

    Examples Magnesium-containing products such as antacids Intervention Avoid use of magnesium-containing products and doxercalciferol in patients on chronic renal dialysis. (Fachinformation zu Doxercalciferol, Arzneimittelwechselwirkungen)

  • EltrombopagOATP1B1-HemmerSchwerwiegend

    Take ALVAIZ at least 2 hours before or 4 hours after any medications or products containing polyvalent cations, such as antacids, dairy products, and mineral supplements to avoid significant reduction in absorption of ALVAIZ due to chelation [see Dosage and Administration ( 2.4 ), Clinical Pharmacology ( 12.3 )] . (Fachinformation zu Eltrombopag, Arzneimittelwechselwirkungen)

  • EthambutolAntibiotikumSchwerwiegend

    It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration. (Fachinformation zu Ethambutol, Arzneimittelwechselwirkungen)

  • FexofenadinAntihistaminikumSchwerwiegend

    When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions) Stop use and ask a doctor if an allergic reaction to this product occurs. (Fachinformation zu Fexofenadin, Warnhinweise)

  • LanthancarbonatPhosphatbinderSchwerwiegend

    There is a potential for LANTHANUM CARBONATE to interact with compounds that bind to cationic antacids (i.e., aluminum-, magnesium-, or calcium-based); therefore, do not take such compounds within 2 hours of dosing with LANTHANUM CARBONATE. (Fachinformation zu Lanthancarbonat, Arzneimittelwechselwirkungen)

  • MesalazinSalicylatSchwerwiegend

    Antacids Because the dissolution of the coating of the granules in APRISO capsules depends on pH, avoid co-administration of APRISO capsules with antacids [see Dosage and Administration (2) ] . (Fachinformation zu Mesalazin, Arzneimittelwechselwirkungen)

  • NaproxenNSARSchwerwiegend

    Intervention: Concomitant administration of antacids such as magnesium oxide or aluminum hydroxide, and sucralfate with Naproxen Suspension is not recommended. (Fachinformation zu Naproxen, Arzneimittelwechselwirkungen)

  • NatriumpolystyrolsulfonatKaliumpräparatSchwerwiegend

    Cation-Donating Antacids The simultaneous oral administration of Sodium Polystyrene Sulfonate Powder, for Suspension with nonabsorbable cation-donating antacids and laxatives may reduce the resin's potassium exchange capability and increase the risk of systemic alkalosis 7.3 Sorbitol Sorbitol may contribute to the risk of intestinal necrosis [ see Warnings and… (Fachinformation zu Natriumpolystyrolsulfonat, Arzneimittelwechselwirkungen)

  • NitrofurantoinAntibiotikumSchwerwiegend

    If coadministration of nitrofurantoin with antacids containing magnesium trisilicate cannot be avoided, monitor for lack of efficacy [see Clinical Pharmacology (12.3) ]. (Fachinformation zu Nitrofurantoin, Arzneimittelwechselwirkungen)

  • OfloxacinFluorchinolonSchwerwiegend

    • that mineral supplements, vitamins with iron or minerals, calcium-, aluminum- or magnesium-based antacids, sucralfate or didanosine chewable/buffered tablets or the pediatric powder for oral solution should not be taken within the two-hour period before or within the two-hour period after taking ofloxacin (see Drug Interactions ) • that ofloxacin can be taken… (Fachinformation zu Ofloxacin, Vorsichtsmaßnahmen)

  • PazopanibSchwerwiegend

    If concomitant administration with a gastric acid-reducing agent cannot be avoided, consider short-acting antacids in place of PPIs and H2-receptor antagonists. (Fachinformation zu Pazopanib, Arzneimittelwechselwirkungen)

  • PhenytoinAntiepileptikumSchwerwiegend

    Calcium carbonate, aluminum hydroxide, magnesium hydroxide Prevention or Management: Phenytoin and antacids should not be taken at the same time of day Antineoplastic agents (usually in combination) Bleomycin, carboplatin, cisplatin, doxorubicin, methotrexate Antiviral agents Fosamprenavir, nelfinavir, ritonavir Antiepileptic drugs Carbamazepine, vigabatrin Other… (Fachinformation zu Phenytoin, Arzneimittelwechselwirkungen)

  • Raltegravirantiretrovirales ArzneimittelSchwerwiegend

    Table 8: Selected Drug Interactions in Adults Concomitant Drug Class: Drug Name Effect on Concentration of Raltegravir Clinical Comment Metal-Containing Antacids aluminum and/or magnesium-containing antacids ↓ Coadministration or staggered administration of aluminum and/or magnesium hydroxide-containing antacids and ISENTRESS is not recommended. (Fachinformation zu Raltegravir, Arzneimittelwechselwirkungen)

  • RifampicinAntibiotikumSchwerwiegend

    Quinine Prevention or Management : Avoid concomitant use Decrease AUC by 75%-85% Telithromycin Decrease AUC by 86% Theophylline Decrease exposure by 20%-40% Effect of Other Drugs on Rifampin Concomitant antacid administration may reduce the absorption of rifampin. (Fachinformation zu Rifampicin, Arzneimittelwechselwirkungen)

  • Rilpivirinantiretrovirales ArzneimittelSchwerwiegend

    Antacids should only be administered either at least 2 hours before or at least 4 hours after EDURANT or EDURANT PED. ↓ rilpivirine (concomitant intake) Anticonvulsants: carbamazepine oxcarbazepine phenobarbital phenytoin ↓ rilpivirine Coadministration is contraindicated with EDURANT or EDURANT PED [see Contraindications (4) ] . (Fachinformation zu Rilpivirin, Arzneimittelwechselwirkungen)

  • RiociguatVasodilatatorSchwerwiegend

    Antacids: Antacids such as aluminum hydroxide/magnesium hydroxide decrease riociguat absorption and should not be taken within 1 hour of taking Adempas [see Clinical Pharmacology (12.3) ]. (Fachinformation zu Riociguat, Arzneimittelwechselwirkungen)

  • RisedronsäureBisphosphonatSchwerwiegend

    Calcium supplements, antacids, magnesium-based supplements or laxatives, and iron preparations interfere with the absorption of Risedronate sodium delayed-release and should not be taken together. (Fachinformation zu Risedronsäure, Arzneimittelwechselwirkungen)

Mittelschwere Wechselwirkungen (33)

  • AcalabrutinibMittelschwer

    Gastric Acid Reducing Agents Clinical Effect • Co-administration of CALQUENCE with a proton pump inhibitor, H2-receptor antagonist, or antacid may decrease acalabrutinib plasma concentrations [see Clinical Pharmacology (12.3) ] . (Fachinformation zu Acalabrutinib, Arzneimittelwechselwirkungen)

  • Amfetamin und DexamfetaminZNS-StimulansMittelschwer

    Alkalinizing agents (GI antacids and urinary): These agents increase blood levels of amphetamine. (Fachinformation zu Amfetamin und Dexamfetamin, Arzneimittelwechselwirkungen)

  • Atazanavirantiretrovirales ArzneimittelMittelschwer

    Reduced plasma concentrations of atazanavir are expected if proton-pump inhibitors, antacids, buffered medications, or H 2 -receptor antagonists are administered with REYATAZ [see Dosage and Administration ( 2.3 , 2.4 , 2.5 and 2.6) ] . (Fachinformation zu Atazanavir, Arzneimittelwechselwirkungen)

  • BosutinibMittelschwer

    Proton Pump Inhibitors (PPI) As an alternative to PPIs, use short-acting antacids or H2 blockers and separate dosing by more than 2 hours from BOSULIF dosing. (Fachinformation zu Bosutinib, Arzneimittelwechselwirkungen)

  • CefdinirCephalosporinMittelschwer

    Drug Interactions: Antacids (Aluminum- or Magnesium-Containing): Concomitant administration of 300 mg cefdinir capsules with 30 mL Maalox ® TC suspension reduces the rate (C max ) and extent (AUC) of absorption by approximately 40%. (Fachinformation zu Cefdinir, Arzneimittelwechselwirkungen)

  • CefpodoximCephalosporinMittelschwer

    Drug Interactions Antacids Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H 2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively. (Fachinformation zu Cefpodoxim, Arzneimittelwechselwirkungen)

  • ChloroquinMalariamittelMittelschwer

    Drug Interactions Antacids and kaolin: Antacids and kaolin can reduce absorption of chloroquine; an interval of at least 4 hours between intake of these agents and chloroquine should be observed. (Fachinformation zu Chloroquin, Arzneimittelwechselwirkungen)

  • CiprofloxacinFluorchinolonMittelschwer

    Drug(s) Affecting Pharmacokinetics of Ciprofloxacin Antacids, Sucralfate, Multivitamins and Other Products Containing Multivalent Cations (magnesium/aluminum antacids; polymeric phosphate binders (for example, sevelamer, lanthanum carbonate); sucralfate; Videx ® (didanosine) chewable/buffered tablets or pediatric powder; other highly buffered drugs; or products… (Fachinformation zu Ciprofloxacin, Arzneimittelwechselwirkungen)

  • DeferipronEisenpräparatMittelschwer

    Polyvalent Cations Deferiprone has the potential to bind polyvalent cations (e.g., iron, aluminum, and zinc); allow at least a 4-hour interval between FERRIPROX and other medications (e.g., antacids), or supplements containing these polyvalent cations [see Dosage and Administration ( 2.2 ) ] . (Fachinformation zu Deferipron, Arzneimittelwechselwirkungen)

  • DiflunisalNSARMittelschwer

    Antacids Concomitant administration of antacids may reduce plasma levels of diflunisal. (Fachinformation zu Diflunisal, Arzneimittelwechselwirkungen)

  • DigoxinDigitalisglykosidMittelschwer

    Digoxin Concentrations Decreased Acarbose, Activated Charcoal, Albuterol, Antacids, certain cancer chemotherapy or radiation therapy, Cholestyramine, Colestipol, Exenatide, Kaolin-pectin, Meals High in Bran, Metoclopramide, Miglitol, Neomycin, Penicillamine, Phenytoin, Rifampin, St. (Fachinformation zu Digoxin, Arzneimittelwechselwirkungen)

  • Elvitegravir, Cobicistat, Emtricitabin und Tenofovirantiretrovirales ArzneimittelMittelschwer

    Medications or Oral Supplements Containing Polyvalent Cations (e.g., Mg, Al, Ca, Fe, Zn): calcium or iron supplements, including multivitamins cation-containing antacids or laxatives sucralfate buffered medications ↓ elvitegravir Separate GENVOYA and administration of medications, antacids, or oral supplements containing polyvalent cations by at least 2 hours. (Fachinformation zu Elvitegravir, Cobicistat, Emtricitabin und Tenofovir, Arzneimittelwechselwirkungen)

  • Emtricitabin, Rilpivirin und Tenofovirantiretrovirales ArzneimittelMittelschwer

    Drug Interactions Concomitant Drug Class: Drug Name Effect on Concentration Increase = ↑; Decrease = ↓; No Effect = ↔ Clinical Comment Antacids: antacids (e.g., aluminum, magnesium hydroxide, or calcium carbonate) ↔ RPV (antacids taken at least 2 hours before or at least 4 hours after RPV) ↓ RPV (concomitant intake) Administer antacids at least 2 hours before… (Fachinformation zu Emtricitabin, Rilpivirin und Tenofovir, Arzneimittelwechselwirkungen)

  • ErlotinibMittelschwer

    For H-2 receptor antagonists and antacids, modify the dosing schedule [see Dosage and Administration (2.4) ]. (Fachinformation zu Erlotinib, Arzneimittelwechselwirkungen)

  • EtodolacNSARMittelschwer

    However, antacids can decrease the peak concentration reached by 15% to 20% but have no detectable effect on the time-to-peak. (Fachinformation zu Etodolac, Arzneimittelwechselwirkungen)

  • Fosamprenavirantiretrovirales ArzneimittelMittelschwer

    Antacid: MAALOX TC ↓Amprenavir Use with caution when administered at the same time. (Fachinformation zu Fosamprenavir, Arzneimittelwechselwirkungen)

  • FosinoprilACE-HemmerMittelschwer

    Antacids In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administrated alone, suggesting that antacids may impair absorption of fosinopril. (Fachinformation zu Fosinopril, Arzneimittelwechselwirkungen)

  • Fosinopril und HydrochlorothiazidACE-HemmerMittelschwer

    Antacids In a clinical pharmacology study, serum levels and urinary excretion of fosinoprilat were reduced when fosinopril was coadministered with an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) suggesting that antacids may impair absorption of fosinopril. (Fachinformation zu Fosinopril und Hydrochlorothiazid, Arzneimittelwechselwirkungen)

  • GabapentinAntiepileptikumMittelschwer

    Maalox ® (aluminum hydroxide, magnesium hydroxide) The mean bioavailability of gabapentin was reduced by about 20% with concomitant use of an antacid (Maalox ® ) containing magnesium and aluminum hydroxides. (Fachinformation zu Gabapentin, Arzneimittelwechselwirkungen)

  • GefitinibMittelschwer

    Drugs Affecting Gastric pH Drugs that elevate gastric pH (e.g., proton pump inhibitors, histamine H 2 -receptor antagonists, and antacids) may reduce plasma concentrations of gefitinib. (Fachinformation zu Gefitinib, Arzneimittelwechselwirkungen)

  • HydroxychloroquinQT-verlängerndes ArzneimittelMittelschwer

    Antacids and kaolin Antacids and kaolin can reduce absorption of chloroquine; an interval of at least 4 hours between intake of these agents and chloroquine should be observed. (Fachinformation zu Hydroxychloroquin, Arzneimittelwechselwirkungen)

  • ItraconazolAzol-AntimykotikumMittelschwer

    Gastrointestinal Drugs Drugs that reduce gastric acidity e.g. acid neutralizing medicines such as aluminum hydroxide, or acid secretion suppressors such as H 2 - receptor antagonists and proton pump inhibitors (e.g., omeprazole). (Fachinformation zu Itraconazol, Arzneimittelwechselwirkungen)

  • KetoconazolAzol-AntimykotikumMittelschwer

    Drugs that may decrease ketoconazole plasma concentrations Drugs that reduce the gastric acidity (e.g., acid neutralizing medicines such as aluminum hydroxide, or acid secretion suppressors such as H 2 -receptor antagonists and proton pump inhibitors) impair the absorption of ketoconazole from ketoconazole tablets. (Fachinformation zu Ketoconazol, Arzneimittelwechselwirkungen)

  • Ledipasvir und SofosbuvirVirostatikumMittelschwer

    Antacids (e.g., aluminum and magnesium hydroxide) It is recommended to separate antacid and ledipasvir and sofosbuvir administration by 4 hours. (Fachinformation zu Ledipasvir und Sofosbuvir, Arzneimittelwechselwirkungen)

  • LevofloxacinFluorchinolonMittelschwer

    Interacting Drug Interaction Multivalent cation-containing products including antacids, metal cations or didanosine Absorption of levofloxacin is decreased when the tablet or oral solution formulation is taken within 2 hours of these products. (Fachinformation zu Levofloxacin, Arzneimittelwechselwirkungen)

  • MefenaminsäureNSARMittelschwer

    Antacid Clinical Impact: Concomitant ingestion of antacids containing magnesium hydroxide has been shown to significantly increase the rate and extent of mefenamic acid absorption [See Clinical Pharmacology ( 12.3 )] Intervention: Concomitant use of mefenamic acid and antacids is not generally recommended because of possible increased adverse events. (Fachinformation zu Mefenaminsäure, Arzneimittelwechselwirkungen)

  • MycophenolatImmunsuppressivumMittelschwer

    See FPI for drugs that may interfere with systemic exposure and reduce mycophenolate mofetil efficacy: antacids with magnesium or aluminum hydroxide, proton pump inhibitors, drugs that interfere with enterohepatic recirculation, telmisartan, calcium-free phosphate binders. (Fachinformation zu Mycophenolat, Arzneimittelwechselwirkungen)

  • OctreotidMittelschwer

    Proton Pump Inhibitors, H2-receptor Antagonists, or Antacids: may decrease bioavailability of MYCAPSSA and the MYCAPSSA dose may need to be increased (‎ 7 ). (Fachinformation zu Octreotid, Arzneimittelwechselwirkungen)

  • RosuvastatinStatinMittelschwer

    Table 6: Drug Interactions that Decrease the Efficacy of Rosuvastatin Tablets Antacids Prevention or Management In patients taking an antacid, administer rosuvastatin tablets at least 2 hours before the antacid. (Fachinformation zu Rosuvastatin, Arzneimittelwechselwirkungen)

  • Sofosbuvir und VelpatasvirVirostatikumMittelschwer

    Antacids (e.g., aluminum and magnesium hydroxide) Separate antacid and VOSEVI administration by 4 hours. (Fachinformation zu Sofosbuvir und Velpatasvir, Arzneimittelwechselwirkungen)

  • TacrolimusImmunsuppressivumMittelschwer

    Other drugs, such as: Magnesium and aluminum hydroxide antacids Metoclopramide May increase tacrolimus whole blood trough concentrations and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation) [see Warnings and Precautions ( 5.7 , 5.10 , 5.11 )]. (Fachinformation zu Tacrolimus, Arzneimittelwechselwirkungen)

  • TadalafilPDE-5-HemmerMittelschwer

    Antacids — Simultaneous administration of an antacid (magnesium hydroxide/aluminum hydroxide) and tadalafil reduced the apparent rate of absorption of tadalafil without altering exposure (AUC) to tadalafil. (Fachinformation zu Tadalafil, Arzneimittelwechselwirkungen)

  • TrospiumchloridAnticholinergikumMittelschwer

    Exposure to trospium on average was comparable in the presence of and without antacid, however, some individuals demonstrated increases or decreases in trospium exposure in the presence of antacid. (Fachinformation zu Trospiumchlorid, Arzneimittelwechselwirkungen)

Geringfügige Erwähnungen (20)

  • AlendronsäureBisphosphonatGeringfügig

    Calcium supplements, antacids or oral medications containing multivalent cations interfere with absorption of alendronate. (Fachinformation zu Alendronsäure, Arzneimittelwechselwirkungen)

  • Cabotegravirantiretrovirales ArzneimittelGeringfügig

    Concomitant Drug Class: Drug Name Effect on Concentration Clinical Comment Antacids containing polyvalent cations (e.g., aluminum or magnesium hydroxide, calcium carbonate) ↓Cabotegravir Administer antacid products at least 2 hours before or 4 hours after taking VOCABRIA. (Fachinformation zu Cabotegravir, Arzneimittelwechselwirkungen)

  • CefaclorCephalosporinGeringfügig

    Drug Interactions Antacids The extent of absorption of cefaclor extended-release tablets is diminished if magnesium or aluminum hydroxide-containing antacids are taken within 1 hour of administration; H 2 blockers do not alter either the rate or the extent of absorption of cefaclor extended-release tablets. (Fachinformation zu Cefaclor, Arzneimittelwechselwirkungen)

  • CefuroximCephalosporinGeringfügig

    Administer cefuroxime axetil at least 1 hour before or 2 hours after administration of short-acting antacids. (Fachinformation zu Cefuroxim, Arzneimittelwechselwirkungen)

  • Darunavir und Cobicistatantiretrovirales ArzneimittelGeringfügig

    …drug-drug interactions have not been observed or are not anticipated with concomitant use of darunavir and cobicistat with rilpivirine, dolutegravir, raltegravir, abacavir, emtricitabine, emtricitabine/tenofovir alafenamide, tenofovir DF, lamivudine, stavudine, zidovudine, or acid modifying medications (antacids, H 2 -receptor antagonists, proton pump inhibitors). (Fachinformation zu Darunavir und Cobicistat, Arzneimittelwechselwirkungen)

  • DemeclocyclinTetracyclin-AntibiotikumGeringfügig

    Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and by iron-containing preparations. (Fachinformation zu Demeclocyclin, Arzneimittelwechselwirkungen)

  • DiazepamBenzodiazepinGeringfügig

    Antacids Diazepam peak concentrations are 30% lower when antacids are administered concurrently. (Fachinformation zu Diazepam, Arzneimittelwechselwirkungen)

  • Dolutegravirantiretrovirales ArzneimittelGeringfügig

    TIVICAY or TIVICAY PD should be taken 2 hours before or 6 hours after taking cation-containing antacids or laxatives, sucralfate, oral supplements containing iron or calcium, or buffered medications. (Fachinformation zu Dolutegravir, Arzneimittelwechselwirkungen)

  • DoxycyclinTetracyclin-AntibiotikumGeringfügig

    Absorption of tetracyclines, including doxycycline hyclate is impaired by antacids containing aluminum, calcium, or magnesium, bismuth subsalicylate and iron-containing preparations. (Fachinformation zu Doxycyclin, Arzneimittelwechselwirkungen)

  • HyoscyaminAnticholinergikumGeringfügig

    Drug interactions may occur when anticholinergics are used with the following medications: antacids, antidiarrheals (adsorbent), other anticholinergics, antimyasthenics, cyclopropane, haloperidol, ketoconazole, metoclopramide, opioid (narcotic) analgesics, and potassium chloride. (Fachinformation zu Hyoscyamin, Arzneimittelwechselwirkungen)

  • IbandronsäureBisphosphonatGeringfügig

    Calcium supplements, antacids and some oral medications may interfere with absorption of ibandronate. (Fachinformation zu Ibandronsäure, Arzneimittelwechselwirkungen)

  • KetoprofenNSARGeringfügig

    It is possible that minor adverse symptoms of gastric intolerance may be prevented by administering Ketoprofen Capsules, USP with antacids, food, or milk. (Fachinformation zu Ketoprofen, Warnhinweise und Vorsichtsmaßnahmen)

  • LactuloseAbführmittelGeringfügig

    Drug Interactions Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH. (Fachinformation zu Lactulose, Arzneimittelwechselwirkungen)

  • MethylscopolaminAnticholinergikumGeringfügig

    Concomitant administration with antacids may interfere with the absorption of methscopolamine bromide. (Fachinformation zu Methylscopolamin, Arzneimittelwechselwirkungen)

  • MiglitolAntidiabetikumGeringfügig

    In 12 healthy males, concomitantly administered antacid did not influence the pharmacokinetics of miglitol. (Fachinformation zu Miglitol, Arzneimittelwechselwirkungen)

  • MinocyclinTetracyclin-AntibiotikumGeringfügig

    Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (Fachinformation zu Minocyclin, Arzneimittelwechselwirkungen)

  • Raloxifenselektiver Estrogenrezeptormodulator (SERM)Geringfügig

    Other Concomitant Medications EVISTA can be concomitantly administered with ampicillin, amoxicillin, antacids, corticosteroids, and digoxin [see Clinical Pharmacology ( 12.3 )] . (Fachinformation zu Raloxifen, Arzneimittelwechselwirkungen)

  • TetracyclinTetracyclin-AntibiotikumGeringfügig

    Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate. (Fachinformation zu Tetracyclin, Arzneimittelwechselwirkungen)

  • Aluminum-based Antacids : May interfere with the action of URSO 250 and URSO Forte by reducing its absorption. (Fachinformation zu Ursodesoxycholsäure, Arzneimittelwechselwirkungen)

  • VardenafilPDE-5-HemmerGeringfügig

    Other Drug Interactions No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, an antacid based on magnesium-aluminum hydroxide, and ranitidine. (Fachinformation zu Vardenafil, Arzneimittelwechselwirkungen)

Keine relevante Wechselwirkung berichtet (16)

  • CefprozilCephalosporinKeine Wechselwirkung

    The bioavailability of the capsule formulation of cefprozil was not affected when administered 5 minutes following an antacid. (Fachinformation zu Cefprozil, Arzneimittelwechselwirkungen)

  • DikaliumclorazepatBenzodiazepinKeine Wechselwirkung

    In bioavailability studies with normal subjects, the concurrent administration of antacids at therapeutic levels did not significantly influence the bioavailability of clorazepate dipotassium tablets. (Fachinformation zu Dikaliumclorazepat, Arzneimittelwechselwirkungen)

  • DofetilidAntiarrhythmikumKeine Wechselwirkung

    If a patient requires dofetilide and anti-ulcer therapy, it is suggested that omeprazole, ranitidine, or antacids (aluminum and magnesium hydroxides) be used as alternatives to cimetidine, as these agents have no effect on the pharmacokinetic profile of dofetilide. (Fachinformation zu Dofetilid, Arzneimittelwechselwirkungen)

  • Doravirinantiretrovirales ArzneimittelKeine Wechselwirkung

    …clinically significant changes in concentration were observed for doravirine when co-administered with the following agents: dolutegravir, TDF, lamivudine, elbasvir and grazoprevir, ledipasvir and sofosbuvir, ritonavir, ketoconazole, aluminum hydroxide/magnesium hydroxide/simethicone containing antacid, pantoprazole, and methadone [see Clinical Pharmacology (12.3) ]. (Fachinformation zu Doravirin, Arzneimittelwechselwirkungen)

  • Efavirenzantiretrovirales ArzneimittelKeine Wechselwirkung

    Drugs Without Clinically Significant Interactions with Efavirenz No dosage adjustment is recommended when efavirenz is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lorazepam, nelfinavir, nucleoside reverse transcriptase inhibitors (abacavir, emtricitabine, lamivudine, stavudine, tenofovir… (Fachinformation zu Efavirenz, Arzneimittelwechselwirkungen)

  • Efavirenz, Lamivudin und Tenofovirantiretrovirales ArzneimittelKeine Wechselwirkung

    Drugs without Clinically Significant Interactions No dosage adjustment is recommended when SYMFI is administered with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, and lorazepam. (Fachinformation zu Efavirenz, Lamivudin und Tenofovir, Arzneimittelwechselwirkungen)

  • FamciclovirVirostatikumKeine Wechselwirkung

    …Penciclovir No clinically significant alterations in penciclovir pharmacokinetics were observed following single-dose administration of 500 mg famciclovir after pretreatment with multiple doses of allopurinol, cimetidine, theophylline, zidovudine, promethazine, when given shortly after an antacid (magnesium and aluminum hydroxide), or concomitantly with emtricitabine. (Fachinformation zu Famciclovir, Arzneimittelwechselwirkungen)

  • FelbamatAntiepileptikumKeine Wechselwirkung

    Effects of Antacids on Felbatol ® The rate and extent of absorption of a 2400 mg dose of Felbatol ® as monotherapy given as tablets was not affected when coadministered with antacids. (Fachinformation zu Felbamat, Arzneimittelwechselwirkungen)

  • MexiletinAntiarrhythmikumKeine Wechselwirkung

    Mexiletine does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to mexiletine, has been reported to lower serum digoxin levels. (Fachinformation zu Mexiletin, Arzneimittelwechselwirkungen)

  • NabumetonNSARKeine Wechselwirkung

    Concomitant administration of an aluminum-containing antacid had no significant effect on the bioavailability of 6MNA. (Fachinformation zu Nabumeton, Arzneimittelwechselwirkungen)

  • OlanzapinAntipsychotikumKeine Wechselwirkung

    Cimetidine and Antacids — Single doses of cimetidine (800 mg) or aluminum- and magnesium-containing antacids did not affect the oral bioavailability of olanzapine. (Fachinformation zu Olanzapin, Arzneimittelwechselwirkungen)

  • OseltamivirVirostatikumKeine Wechselwirkung

    …Clinically Significant Drug Interaction with TAMIFLU No dose adjustments are needed for either oseltamivir or the concomitant drug when coadministering oseltamivir with amoxicillin, acetaminophen, aspirin, cimetidine, antacids (magnesium and aluminum hydroxides and calcium carbonates), rimantadine, amantadine, or warfarin [see Clinical Pharmacology (12.3) ] . (Fachinformation zu Oseltamivir, Arzneimittelwechselwirkungen)

  • PosaconazolAzol-AntimykotikumKeine Wechselwirkung

    No clinically relevant effects on the pharmacokinetics of Noxafil delayed-release tablets were observed during concomitant use with antacids, H 2 -receptor antagonists and proton pump inhibitors, and metoclopramide [see Clinical Pharmacology (12.3) ] . (Fachinformation zu Posaconazol, Arzneimittelwechselwirkungen)

  • Telmisartan und AmlodipinAngiotensin-II-Rezeptorblocker (Sartan)Keine Wechselwirkung

    The following have no clinically relevant effects on the pharmacokinetics of amlodipine: cimetidine, grapefruit juice, magnesium and aluminum hydroxide antacid, sildenafil. (Fachinformation zu Telmisartan und Amlodipin, Arzneimittelwechselwirkungen)

  • ValproinsäureAntiepileptikumKeine Wechselwirkung

    Drugs for which either no interaction or a likely clinically unimportant interaction has been observed Antacids A study involving the co-administration of valproate 500 mg with commonly administered antacids (Maalox, Trisogel, and Titralac - 160 mEq doses) did not reveal any effect on the extent of absorption of valproate. (Fachinformation zu Valproinsäure, Arzneimittelwechselwirkungen)

  • ZiprasidonAntipsychotikumKeine Wechselwirkung

    Antacid The co-administration of 30 mL of Maalox® with ziprasidone did not affect the pharmacokinetics of ziprasidone. (Fachinformation zu Ziprasidon, Arzneimittelwechselwirkungen)

Prüfen Sie Antazida (Tums, Maalox, Mylanta) gegen alles, was Sie einnehmen. Fügen Sie Ihre gesamte Liste hinzu; alle Paare werden auf einmal geprüft.

Im Wechselwirkungscheck öffnen

Keine medizinische Beratung. Der Schweregrad gibt die Formulierung der Fachinformation wieder, nicht Ihre persönlichen Umstände. Eine als „schwerwiegend“ eingestufte Wechselwirkung kann unter Aufsicht Routine sein, und eine „geringfügige“ kann bei hohen Dosen von Bedeutung sein. Fragen Sie in einer Apotheke nach.